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Bacterial ribosomes have been shown to be specific antigens in
immunoassays. However, N. gonorrhoeae ribosomes have not been
tested for use in a reliable immunological test for the detection
of gonorrhea, In the present study, in vitro macrophage migration
inhibition (MIF) tests were employed to characterize the cellmediated immune (CMI) response of gonorrhea patients to a crude
gonococcal ribosome preparation. It was ascertained that lymph
ocytes from patients had become sensitized to homologous ribosomes
within 10 days of contact of the disease and lose sensitization
8 to 16 weeks post-therapy. A similar but non-specific response
was observed with lymphocytes from patients and control subjects,
when incubated with gonococcal endotoxin. Differential criteria
for diagnosis were established according to lymphocyte responses
to the two preparations, and were used in correct diagnosis of 7
of 9 culture-positive patients and 8 of 9 negative controls. Re
sults from this research warrant the investigation of chimpanzee
or human infection for
vivo responses to intradermal adminis
tration of gonococcal ribosomes.
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CHAPTER I
INTRODUCTION

Gonorrhea is currently the number one reported communi
cable disease in the United States.

Yet, for every reported

case it is estimated that there are three cases which go un
reported (2).

The primary reason for this is that gonorrhea

is commonly without symptoms.

Estimates of asymptomatic

female infection range from 40% to 80%, and estimates of
asymptomatic male infection range from 5% to 50% (32, 55).
Without symptoms of infection, infected persons do not seek
diagnosis, and therefore comprise a pool or reservoir of
infection in the population which helps maintain the disease
at epidemic proportions (12, 52),

Despite adequate treatment

procedures, reported cases of gonorrhea doubled in the six
years from 1966-1972, with 624,000 cases reported in the U.S.
in 1971 (10).

The need is apparent for a means by which this

epidemic may be controlled.
Researchers have studied the possibility of developing
a protective vaccine against Neisseria gonorrhoeae infection.
Arko (4, 5) was able to establish a protective immunity in
chimpanzees with a formalinized whole-cell vaccine; protec
tion lasted ten weeks.

Others have stimulated increased
1

2

antibody levels by vaccination, without evident protective
effects (30), although Drutz (24) has reported that patients
with a history of gonococcal infection are more difficult to
infect experimentally.

Recent reports indicate that gonococ

cal ribosomes provide an effective vaccine, which stimulated
inhibition of N. gonorrhoeae growth in subcutaneous chambers
implanted in guinea pigs (16).

Although development of a

vaccine would be ideal in dealing with the epidemic, endeav
ors to date have revealed less than desirable results.

The

major barrier to developing a vaccine is lack of a gonococ
cal antigen which will elicit a protective response and will
continue to elicit that response for long periods of time.
Investigations to date have been able to do no better than
mimic the natural infection which, because it is localized
and somewhat isolated from the immune system, elicits an
antibody response that lasts for only a few months posttherapy and fails to elicit a detectable protective immunity
(38),

Therefore, investigators have focused on an approach to
screen large populations in order to detect and treat this
pool of infection.

Diagnosis is presently based on the abil

ity to culture N. gonorrhoeae organisms from the vagina or
male urethra.

In 1973 a gonococcal culture screening pro

gram was employed by the United States Public Health Service
in an attempt to identify the reservoir of infection in the
population (2).

The program detected 242,276 positives from
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nearly 5 million examined in 1973, or approximately 5 per
cent.

Though seemingly significant, this segment of the

population examined represents a very small fraction of the
total population at risk.

The method of culturing is suffi

cient for laboratory diagnosis (70-90% reliable) (14, 55, 58,
72), but is time consuming and expensive for application in
a large scale screening program.
Epidemiologically, a system of 5 to 8 minute interviews
with culture-positive patients, in order to identify sexual
partners, has detected many asymptomatic victims (10, 55),
Such methods are expensive, time consuming, and inefficient
at locating the partners.

Therefore, this approach is im

practical as a single screening tool, although useful as an
adjunct.
In the search for reliable and easily administered di
agnostic tests, researchers have turned to examination of
patients' immune response.

Studies have focused primarily

on the humoral (circulating antibody) response, with various
gonococcal preparations used as antigens.

Complement fixa

tion tests using N. gonorrhoeae protoplasm and protoplasm
fractionated through Sephadex as antigens have detected
higher serum antibody levels in patients than in controls
(20, 38, 64, 68, 86).

Gel immunodiffusion (13), micropreci-

pitin (15, 67), and micro-flocculation with gonococcal ex
tracts adhered to cholesterol-lecithin particles (66) have
been studied.

These tests lack specificity and sensitivity.
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yielding a high percentage of false positive and false nega
tive diagnoses.

Radioimmunoassay with pilin and partially

defined cellular preparations used as antigens, has been the
most sensitive method examined to date (38, 53).

These re

quire simplification of technique and adaptation to equipment
commonly available in clinical diagnostic laboratories, be
fore being employed as a tool to screen for the pool of
asymptomatic infections.
Cell-mediated immunity (CMI) or delayed hypersensiti
vity has been shown be David et aj^. (21, 22, 23) to be as
specific as humoral immunity in non-gonococcal systems.
With ^ vitro and ^ vivo methodologies of delayed hypersen
sitivity, he demonstrated no cross reactivity to antigens
with animals sensitized to PPD, ovalbumin, and toxoid.

Thor

et al. (82) found similar specificity with PPD, histoplasmin,
and coccidioidin.

Such specificity of delayed hypersensi

tivity is the basis for tuberculosis skin test diagnosis.
Examination of CMI to gonococcal infection has received
much less consideration than has humoral testing.

In

studies carried out early in this century, various gonococcal
extracts were employed as antigens in skin tests on patients.
Whole cells, autolysis extracts, and other N. gonorrhoeae
culture filtrates revealed cutaneous induration 24 h follow
ing injection (17, 35, 40, 47).

These tests were abandoned

with the inception and widespread use of penicillin treat
ment.

Hot until the 1970's did investigators resume study of
CMI in gonococcal patients.

Kraus et a2. (49) used a lyo-

philized gonococcal sonicate as antigen and demonstrated CMI
by dm vitro blastogenesis of lymphocytes taken from men with
repeated gonococcal urethritis.

These studies failed to

show significant differences in blastogenesis between con
trols and patients having had only one infection.

Grimble

and Mclllmurray (31) in 1973 found 86% positive CMI response
in vitro by patients' lymphocytes to a cell sonicate super
natant fluid (protoplasm).

They found that lymphocytes

became reactive within 4 to 5 days after contraction of in
fection.

Lymphocytes from patients did not respond to simi

lar antigen preparations from the closely related Neisseria
meningitidis organism.

Esquenazi and Streitfeld (26, 27)

found in both the rabbit and human system that

vitro

lymphocyte blastogenesis to various protoplasmic fractions
disappeared 5 to 6 weeks after vaccination (rabbit) or treat
ment (human).
Most humoral and CMI immunological tests lack an anti
gen which is specific to N. gonorrhoeae.

The antigen used

must be one to which infected persons are sensitive, and
which does not cross react with persons sensitive to closely
related organisms.

Present evidence indicates that ribosoities

of each species of bacteria are antigenically specific for
that organism (18, 59, 61).
ribosomal subunits

Otaka et

(60) found the 30S

of Escherichia coli strains K12 and B to
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differ in one or more ribosomal proteins.

Their work demon

strated that some ribosomal proteins from 2 strains of the
same species are electrophoretically identical, yet some are
different.

Alberghina and Suskind (1) found that animals

immunized with Neurospora crassa responded by making anti
bodies which precipitated N. crassa ribosomes.

Sarkar and

Som (69) immunized rabbits with ribosomal protein of plant,
rat, E. coli, and yeast, and found reactions with immuno
diffusion tests only with homologous ribosomal protein.
Judd and Koostra (44, 48) using various cell wall, pilin,
protoplasmic, and ribosomal preparations (crude ribosomes,
50S, 30S, ribosomal RNA, and ribosomal protein) demonstrated
CMI in guinea pigs sensitized by whole cell N. gonorrhoeae
vaccinations.

They found that crude ribosomes were specific

for guinea pigs sensitized to the homologous organisms, and
minimal cross reactivity with ribosomes from closely related
N. meningitidis organisms.
Other investigators have used ribosomes as immunogens
to vaccinate animals against various microorganisms of
tumors.
nogenic.

These studies demonstrated that ribosomes are immu
Zatti ^ aA. (94) were able to protect rats from

Yoshida ascites tumor by injection of homologous ribosomes.
Similar protective immunity has been demonstrated in experi
mental animals against Streptococcus pyogenes (70), Staphy
lococcus aureus (87, 88), Diplococcus pneumoniae (79), Ngonorrhoeae (16), Mycobacterium tuberculosis (90, 91, 92,
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93), and Salmonella typhimurium (39, 43, 63, 84).

Johnson

(43) found that the protection afforded mice against Salmon
ella typhimurium was specific; i-.e., it did not provide pro
tection against challenge with Salmonella enteritidis or
Salmonella cholerae-suis.
Ribosomes may be immunogens, antigens to detect humoral
immunity, and antigens involved in CMI.

Baker et

(6, 7)

demonstrated CMI induced in rabbits to BCG crude ribosomes
and a "30S-50S" pool of BCG ribosomes by skin testing, MIF
testing, and skin reactive factor testing.

Smith and Bigley

(73, 74) demonstrated that ribosomal immunization would pro
tect mice from 5000

of Salmonella typhimurium.

This

protection was transferred to normal mice by peritoneal
exudate cells, lymph node cells, or spleen cells, but not by
serum.

Judd and Koostra (44, 48), as mentioned above, dem

onstrated CMI to N. gonorrhoeae ribosomes in sensitized
guinea pigs, and showed a correlation between ^ vitro macro
phage migration inhibition (MIF) tests of CMI and

vivo

skin testing.
Lipopolysaccharide (LPS) from gram-negative bacteria
has shown to cause lymphocytes to mimic CMI (33, 34, 62, 75).
These investigators have demonstrated that LPS may inhibit
cell migration in MIF tests, or stimulate blastogenesis in
in vitro lymphocyte transformation tests.

This has opened

a major criticism of ribosomal immunology since ribosomal
preparations from gram-negative bacteria almost certainly
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are contaminated with LPS during their isolation.

Therefore,

LPS contained withing ribosomal preparations may be respon
sible for results obtained (53).
Many ^ vitro correlates of skin test CMI have been
developed (9, 29, 45, 80, 81, 82, 89).

Most of these measure

lymphokine release from sensitive lymphocytes upon exposure
to antigens.

David et aJ^. (22) discovered that guinea pig

macrophages, when incubated with sensitive lymphoytes, were
inhibited from migrating upon exposure to antigen.

Perito

neal exudate (PE) cells from non-sensitive guinea pigs mixed
in a ratio of 9:1 with PE cells from sensitive guinea pigs
produced positive MIF test results.

Lymphokines released

from the sensitive lymphocytes when exposed to antigen, inhi
bited the non-sensitive PE cells from migrating.

However,

these non-sensitive PE cells, when incubated with sera from
immunized animals, were not inhibited from migrating.

There

fore, CMI is responsible for this phenomenon.
The work of David et a^. (22) presented a method by
which delayed hypersensitivity may be studied ^ vitro with
human lymphocytes.

Guinea pig macrophages may be mixed with

human peripheral lymphocytes in order to perform MIF tests.
If the human lymphocytes are sensitive to the antigen, they
will release MIF to inhibit the guinea pig macrophages from
migrating.
Since LPS within ribosomal preparations may cause lym
phocytes to mimic CMI in vitro, it is necessary to compare
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responses to LPS and ribosomes.

This will determine whether

results from ribosomal preparations as antigen are due to
the ribosomes, and/or to LPS contained within.
Statement of Thesis
Gonorrhea patients have been shown to elicit CMI to
various partially defined antigen preparations.

Homologous

bacterial ribosomes have been used as antigens to demon
strate CMI in many non-gonococcal infections.

Previously,

no studies had been carried out to test whether gonococcal
patients develop CMI to N. gonorrhoeae ribosomes during the
course of infection.
tigation was to:

Therefore, the purpose of this inves

1) determine whether patients, who are

gonococcal culture positive, develop CMI to a N. gonorrhoeae
ribosome preparation, and 2) characterize the moment of
inception, and duration after drug therapy, of sensitization.

CHAPTER II
MATERIALS AND METHODS
Cultivation of Neisseria gonorrhoeae
GC Medium Base (76):

In a 2 liter flat bottom flask (which

provided large surface to volume ratio) the following sub
stances were mixed with one liter of distilled water and
the solution was sterilized by autoclaving:
Proteose peptone #3
Corn starch

GC Supplement:

15 gm
0.1 gm

K^HPO^

4 gm

NaHgPO^

1 gm

NaCl

5 gm

The following substances were dissolved in

100 ml of distilled water and the solution was sterilized by
filtration through a 0.45 wg Millipore filter;
Cocarboxylase
Glutamine

1 mg
0.5 gm

Glucose

20 gm

Modified Thayer-Martin (T-M) Broth:

Twenty ml of GC Supple

ment were added to one liter of sterile GC Medium Base.

The

T-M Broth was incubated at 37°C for 48 h to insure sterility.
10
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Modified T-M Chocolate Agar :

Double strength CG Medium Base

was prepared in 500 ml distilled water.

Ten g of agar were

added, and the mixture was sterilized by autoclaving.
Ten g of hemoglobin (Ditco) were mixed in 500 ml distil
led water and the solution was sterilized by autoclaving.
When the sterilized solutions had cooled to 60°C, 20 ml
of GC Supplement were added to CG Base and agar, and the
mixture was poured into the hemoglobin solution.

The Modi

fied T-M Chocolate Agar was swirled to mix, poured into petri
dishes, and allowed to solidify.

When the Agar was solid,

the petri dishes were sealed with tape to retain moisture,
and refrigerated until needed.
Bacteria:

Neisseria gonorrhoeae strain F62 was obtained

from Dr. J. A. Rudbach, University of Montana.

A stock cul

ture was maintained on T-M Chocolate Agar at 37°C in a
candle jar.

The stock was transferred to new plates routine

ly every 48 h.
Twenty-four hour cultures of N. gonorrhoeae were washed
from agar surfaces into sterile T-M broth.

The broth was

gassed with 5% CO2 for 30 sec and incubated at 37°C on a
wrist action shaker for 48 h (A growth curve was performed
on the batch of cells, and revealed that late log was reached
at 48 h).

Flasks proven to be pure GC by subculturing onto

T-M agar, oxidase reaction, and gram stain, were spun at
5900xg,

4°C for 7 min to pellet the cells.

Yield from one
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liter was approximately 5 g CG.

The pellet was frozen at

-70°C until 50 g of cells had been accumulated.
Ribosome Preparation
Buffers:

"65S" (pH 7.4)

0.015 M MgClg
0.01 M Tris-HCl
0.5 M NH.Cl

Crude Ribosome Isolation:
at 4°C.

All operations were carried out

Fifty g of CG were suspended in 150 ml "65S" buffer.

The suspension was poured over 100 ml ice and left at 4°C
overnight to kill all GC.

The killed cells were pelleted at

700 xg, resuspended in 100 ml "65S" buffer, and disrupted at
13,000psi in a pre-chilled Ribi Cell Fractionator (56).

The

disrupted cell suspension was centrifuged at 48,200xg for
45 min in a Sorvall RCl-B centrifuge to remove cell wall,
cell membrane and other particulate matter.

The supernatant

fluid was centrifuged at 176,000xg for 3 h in a Beckman
L2-65B ultracentrifuge with a Ti 60 rotor head.
was resuspended in 30 ml "65S" buffer overnight.

The pellet
The sus

pension was centrifuged at 48,200xg to remove all particulate
matter, and the ribosomes were pelleted again at 176,000xg
for 3 h.

This "washed'' pellet was resuspended in 10 ml

"65S" overnight and the concentration was adjusted to 5 mg/
ml.

The suspension was divided into 1 ml portions, and

stored at -70°C until needed.
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Purified Ribosomes:

Crude ribosomes isolated as above were

eluted through a Sephadex GlOO column at 4°C.

Fractions

with peak absorbance at 254 nm were collected, sedimentation
coefficient values were determined, and the purified ribo
somes preparation was stored at -70°C.
Determination of Concentration ;

Using an extinction coeffi

cient for ribosomes at 260 nm of 145 (36), the concentration
was assayed with a Beckman DU-2 spectrophotometer.
Concentration = Dilution^x A260 ^

Determination of Protein and RNA Content ;

mg/ml

The ratio of ab

sorbance at 260 nm and 280 nm is characteristically 1.0 for
ribosomes (79).

All preparations used in this study had

ratios ± 4% of that figure.
Determination of Sedimentation Coefficient (S):

A ribosomal

preparation of 5 mg/ml was centrifuged at 260,000xg (60,000
RPM) in a Beckman Model E ultracentrifuge.

Temperature of

the An-D rotor was maintained at 4°C, and the density gradi
ent in the centrifuge cell was monitored every 2 min with
photographs of the schlieren optics.

The distance of the

schlieren peak from the reference hole was measured, analyzed
in a Wang computer with a pre-written sedimentation coeffi
cient program, and apparent sedimentation coefficients were
determined for each peak.

Any baseline perturbation and

peaks other than 30S, 50S, and 7 0S were indicators of the
impurity of the preparation.
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Lipopolysaccharide (LPS) Preparation
Ten g of frozen GC cells were resuspended in 100 ml of
distilled water.

An equal volume of 88% phenol was added

and the suspension was stirred at 65°C for 30 min.

This

suspension was poured into centrifuge tubes and stored at
4°C for 3 days.

The tubes were centrifuged at 1600xg, 4°C

for 1 h and the phenol phase was discarded.

The aqueous

phase was dialyzed against running tap water at room tempera
ture for 7 days, dialyzed at 4°C against deionized distilled
water through three changes of water (every 3 h), lyophiDized, then stored at -70°C.

The lyophilized LPS was resus

pended to 5 mg/ral in "55S" buffer and stored at -70°C until
needed.
Bioassays

Limulus Assay for LPS (25,65):

Ten-fold dilutions of E. coli

LPS, GC LPS, and GC crude ribosomes were made with triple5
distilled water, in dilutions of 10 ng/ml through 0.1 ng/ml.
Limulus amebocyte lysate (LAL) was obtained from Rocky
Mountain Laboratory, Hamilton, Montana.

One-tenth ml limulus

lysate was added to 0.1 ml of the dilution being tested,
mixed with a Vortex mixer in 10 x 75 mm glass pyrogen-free
test tubes, covered with aluminum foil, and incubated in a
37°C waterbath for 60 min.

Tubes were removed, inverted, and

interpreted as positive if the test sample plus LAL clotted
and did not run down the side of the tube when it was inverted.
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I assisted with the Chick Embryo LD^q and pyrogen as
says, as they were performed at the Rocky Mountain Laboratory
in Hamilton, Montana by Dr. K. C. Milner and Robert Pfeifer.
Chick Embryo

Assay for LPS (28):

GC LPS and GC crude

ribosomes diluted in sterile physiological saline were in
jected in 0.1 ml volumes intravenously (i.v.) into 11-day
old chick embryos which had been incubated in a humidified
incubator at 37°C.

They were observed daily by candling for

3 days post-inoculation.

Intravenous inoculation was per

formed into a prominent allantoic vein through a 2 x 5 mm
window in the shell.

The window was made using a hand drill

fitted with two abrasive discs separated by 2 mm; the shell
flap was then lifted off with an 18 gauge needle.

Inocula

tions were performed while candling, using a tuberculin
syringe and 27 gauge needle.
Following inoculation, the eggs were returned to the
incubator and examined as mentioned above for dead embryos.
Ten eggs were used for each dilution.

LD^^ values were cal

culated by the method of Irwin and Cheeseman (41).
Pyrogen Tests for LPS (46);

GC LPS and GC crude ribosomes

diluted in sterile saline were injected in 2 ml volumes into
the marginal ear vein of rabbits weighing 2 to 3 kg.

Temp

eratures were taken by rectally implanted copper-constantan
thermocouples and recorded automatically every 12 min with a
Honeywell Multipoint Recorder for 6 h.

Six rabbits used for
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each dilution were acclimatized to the test area and rectal
thermometers for 1 h before injection.
Febrile responses were plotted on 1 x 1 inch graph paper
with 1°C and one hour equaling 1 inch.

Area under the curve

was measured in square centimeters, and Fever Index 40 (the
minimal dose necessary to produce an area under the curve of
2

40 cm ) was calculated by the method of Keene et a^. (46).
In Vitro Studies of CMI
Patients ;

Ten ml peripheral blood samples were drawn from

persons diagnosed as positive by GC cultivation.

The blood

was transferred to sterile heparinized (30 units/ml blood)
test tubes, and kept at 4°C until transported to the labora
tory.

All samples were collected from the University of

Montana Student Health Service and the Missoula City-County
Health Department by laboratory technicians employed there.
A coded system was employed to assure anonymity of subjects
beyond confines of the Health Service or Health Department.
Medical histories, where relevant, were provided under the
coding system.
Controls:

Graduate students, professors, and employees of

the Microbiology Department at the University of Montana were
assumed gonococcal negative and with no history of infection
based on their word (An assumption which many investigators
may consider invalid).

Ten ml peripheral blood samples were
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drawn by Dr. W. L. Koostra or Bonna Graham, and treated the
same as was positive blood.
BCG+:

Persons vaccinated with BCG at any time in their life

were bled and the blood was treated as above.
Media and Reagents ;

Physiological Saline - 0.85% NaCl was

made in distilled water, sterilized by autoclaving and stored
at 4°C.
Methylcellulose - Methylcellulose (Mallinckrodt, St.
Louis; 1% = 15 centipoise) was added to distilled water and
stored at 4°C.
ACEP (Ammonium Cloride, EDTA, Phosphate) NH^Cl

0.8%

EDTA

0.1%

KH^PO.

0.01%

was mixed in distilled water and the mixture was stored at
4°C.
MEM (Minimal Essential Medium) MEM (Gibco)

0.96%

NaHCO-

0.15%

was made in distilled water and filter sterilized.

One ml of

Penicillin (100 units/ml) plus Streptomycin (100 yg/ml) was
added to each liter of MEM.

The solution was stored at 4°C.

Antigen dilution medium - MEM + 10% PCS (Fetal Calf
Serum - Difco^ + 0.01 M MgCl2.
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Pd (Dulbecco Phosphate Buffer Solution)
NaCl

0.8%

KCl

0.2%

Ha-HPOj.VH^O

0.216%
0.02

was made in distilled water.

The mixture was sterilized by

autoclaving, and stored at 4°C.
Separation of Human White Blood Cells (WBC) (Adapted from
BjzJyum as cited in 19):

Blood was diluted 3-fold with physio

logical saline in sterile test tubes which had been treated
with Siliclade (Clay Adams) ("siliconized").

Two ml methyl-

cellulose was added and mixed with each 10 ml of diluted
blood.

The tube was tilted to a 45 degree angle and the red

blood cells were allowed to settle at room temperature for
30 min.

The WBC-rich supernatant portion was pipetted into

chilled siliconized centrifuge tubes and centrifuged at
230xg, 4°C for 10 min.

The supernatant fluid was discarded

and each cell pellet was resuspended in 2 ml ACEP.

Five ml

more ACEP was added to each tube, mixed, and incubated at
37°C for 5 min to lyse those red blood cells remaining.
Tubes were centrifuged again at 230xg, 4°C for 10 min
to pellet the WBC's.

The supernatant fluid was discarded

and cells were resuspended in 1 ml MEM.

Cell viability was

ascertained on the basis of uptake of 0.4% Trypan Blue.

Five

drops of diluted cells were mixed with one drop of Trypan
Blue and were enumerated in a hemocytometer.

Cell numbers

19

were adjusted to 2 - 4 x 10^ WBC/ml in 1 ml.

The WBC's were

kept in an ice bath until needed.
Collection of Guinea Pig Macrophages ;

Normal guinea pigs

were stimulated by intraperitoneal injection of 20 ml sterile
mineral oil to induce increased numbers of macrophages in
the peritoneal cavity.
Whenever macrophages for MIF testing were needed,
animals were sacrificed and exudate cells were washed from
the peritoneum with 5 0 ml Pd into a chilled beaker.

All

operations from this point on were carried out on ice or at
-4°C.

The Pd was poured into a separatory funnel and the oil

phase was discarded.

The macrophage-rich Pd was centrifuged

at 230xg for 10 min and the supernatant fluid was discarded.
The cells were resuspended and "washed" twice in MEM.

After

the final washing the cells were resuspended in 0.4 ml MEM,
and viability and cell counts were performed with Trypan
Blue.
Antigen Dilutions ;

On the day of testing, a sample of ribo-

somes and a sample of LPS were allowed to thaw at room tem
perature.

These were diluted to 10 pg and 100 yg per ml in

antigen dilution medium.

These were prepared just prior to

assembling the Mackaness chambers.
Macrophage Migration Inhibition Factor (MIF) Tests:

Guinea

pig macrophages were added to the human leukocytes so that
the ratio of guinea pig cells to human leukocytes was
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approximately 3 to 2.

Micro-hematocrit capillary tubes were

filled two-thirds with the suspension of human and guinea pig
cells (approximately 4 x 10^ total cells per tube).

The

tubes were sealed at one end by melting over a micro-burner,
and then centrifuged at 55xg, 4°C for 10 min to pack the
cells.

Tubes were cut at the interface between the packed

cells and supernatant portion.

The packed tubes were attach

ed by the sealed end with grease to the bottom slide in five
sterile mackaness chambers.

The chambers were closed, each

filled with one of the antigen dilutions and one with the
dilution media without antigen.
37°C, and read after 20 h.

They were then incubated at

If possible, four hemotocrit

tubes were used at each dilution,
Reading MIF Tests:

After incubation for 20 h, the pattern

of cell migration from the tubes was enlarged on a Simmon
Omega Model D-2 enlarger with Wollensak 50 mm enlarging
raptur, traced on Artesian Bond paper, and the pattern was
cut out and weighed on a Mettler H20T balance.

The area

(weight) of cell migration, when incubated with no antigen,
was designated as 1.00.

Areas of migration, for cells incu

bated with antigens, were expressed as a decimal fraction of
migration when incubated with no antigen.

Such decimal frac

tion was thereafter designated as an index of migration.
Therefore, if cells migrated 25% less when incubated with
antigen, the index of migration would be expressed as 0.75.
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Statistical Analysis
The Wilcoxon T-test (42) and 2-sample t-test (8) were
used to determine whether the sample of patients and sample
of negative controls had been drawn from different popula
tions (with regards to cell migration indices, or with re
gards to ratios of indices).
performed, as a double check.

Both statistical tests were
Results of the analysis indi

cated similar levels of significance, so only one value of
significance will be reported.
The 2-sample t-test may be used to compute a value of
t by the following equation:
_P - C
t =
where P and C are the mean values of patients and controls
respectively:

2

and

2

are variance values of patients and

controls, and; n and n are the number of individuals in
P
c
the sample of patients and controls. The computed t may be
interpreted for levels of significance from table a of t
values.
The Wilcoxon T-test was used in the case that there may
not be a normal distribution of data values (an assumption
made when using the above 2-sample t-test).

Data from

patients and controls were randomly paired, the differences
between data values of paired subjects calculated, and the
differences ranked according to be absolute value of the
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difference.

The ranks were assigned + or - values according

to whether the difference between paired subjects was + or -.
The value of T was the summation of the + or - ranks (which
ever was least), and significance levels interpreted from an
appropriate T table.

CHAPTER III
RESULTS
GC Growth Curve ;

In order to obtain the optimal ribosome

yield from each culture of bacteria, it was necessary to
determine when they would be in the middle or late exponen
tial phase of growth.

Cultures were therefore harvested at

24 h intervals, and an approximate growth curve was plotted
(Fig. 1).

Results from the growth curve, confirming tradi

tion, indicated 48 h cultures to be at log phase of growth
and the optimal time to harvest.

During log phase, the bac

teria are synthesizing protein rapidly and will have high
yields of ribosomes.
It was observed that 72 h cultures were often difficult
to subculture, indicating late log or death phase.

During

such phases, autolysis and ribonuclease destruction of the
ribosomes would be maximal, and ribosomes isolated from those
cultures would be damaged.

Therefore, all cultures were

harvested at 48 h.
Sedimentation Velocity Determinations:

Subsequent to crude

ribosome isolation it was necessary to examine the prepara
tion so that I could discover the nature of its constituents.
Without such examination it cannot be defined as a ''ribosome"
23
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Fig. 1.

Growth curve of N. gonorrhoeae in modified T-M broth.
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preparation.

Therefore, analytical sedimentation velocity

ultrocentrifugation was performed to determine the purity and
sedimentation coefficient (5) of constituents present (Fig.
2) .

Schlieren optics provided an indication of the sample
present within the centrifuge cell.

Reading the photographs

from left to right, one notices three distinct peaks emerging
in the first frame.

The sedimentation coefficient for each

peak was determined by the rate that each peak moves down
the cell.

The first peak (left) had a sedimentation coeffi

cient of 24.3, second 48.2, and third 66.3.

These values can

be extrapolated to 30S, 50S, and 70S at zero concentration,
revealing that the preparation does contain ribosomes with
out any other cellular constituents at major concentration.
The amplitudes of the peaks are a reflection of the con
centrations of each constituent.

Apparently most of the 70S

ribosomes were dissociated into constituent subunits within
the buffer, because the 30S and SOS peaks represent the
major portion of the ribosomal concentration.

This sample

was the only sample used for MIF tests performed in which
crude ribosomes were tested with antigen.
Bioassays:

LPS contamination of ribosome preparations is an

inevitable result of ribosome isolation from gram-negative
bacteria.

It was therefore necessary to assay for the endo

toxin level within the crude ribosome preparation.

Such

determination would aid in interpreting whether ribosomes or

Schlieren Optics of GC Crude Ribosomes
used in CMI studies
(4.8 itig/ml)
Bar angle 70°

0 min

2 min

4 min

6 min

to

m
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LPS were the antigen within the crude ribosome preparation
responsible for results obtained in the CMI studies.
Limulus amebocyte lysate (LAL) tests were performed with
the crude ribosome and LPS preparations.

The clotting end-

point for GC LPS and GC crude ribosomes was 10^ ng/ml (Table
1).

Although both LPS and crude ribosomes had equivalent

endpoints in this test, it was not conclusive that they had
equivalent levels of endotoxin.

Since the decrement of each

dilution tested was by 10-fold, the endpoint dilution of one
preparation may contain as much as nine times more endotoxin
than the other preparation.
Another possible limitation of the LAL test is its
specificity.

Researchers have demonstrated in studies with

various blood plasma factors that the LAL test will react
positively and clot with nucleoprotein (25).

This suggested

that the LAL may have been reacting with the ribonucleoprotein of the ribosomes.

Because the endotoxin level in the

crude ribosomes was to be so important in interpretation of
the MIF results, we employed other tests of endotoxic acti
vity to further quantify the endotoxin present.
Chick Embryo LD^^ tests were performed as a measure of
endotoxic activity for both the LPS and crude ribosome pre
parations (Table 2).

CELD^^ doses calculated by the method

of Irwin and Cheeseman (41) yielded CELD^^ of 5.3 yg for the
GC LPS and a

CELD^q

of 2.0 yg for the GC crude ribosomes.

Five-fold dilutions were used in performing this test, so

Table 1. Clotting reactions to limulus amebocyte
lysale (LAL) of bacterial preparations.
Concentration
(ng/ml)

Bacterial Preparation
E.
coli
LPS

GC
LPS

GC
crude
Ribosomes

10 =

ND

+

+

10^

+

+

+

10^

ND

+

+

10^

+

-

-

10

ND

-

-

1

-

-

-

0.1

-

-

-

+ = clotting after incubation at 37°C
- = no clotting after incubation at 37°C
ND = not done
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Table 2. Chick embryo responses to injection of GC LPS or
GC crude ribosomes, and determination of Chick Embryo LD-q
(CELD ^Q).
GC
LPS
Dose

Number
inoculated

Live

0.0032

10

0.016

Dead

Live

10

0

10

0

10

10

0

10

0

0.08

10

9

10

0

0.4

10

10

0

10

0

2.0

10

9

1

5

5

10.0

10

2

8

0

10

(yg)

Hem

GC
Crude Ribosomes

1

CELD50*
5.3 yg

Hem

Dead

2.0 ug

Hem = hemorrhage
* = as determined by the method of Irwin and Cheeseman (41).

30
that there is room for error.

The test results, indicate the

crude ribosomes to contain more than twice the endotoxic
activity of the LPS preparation.
Rabbit pyrogen tests were employed as the third test of
the preparations for endotoxin.

Milner and Finkelstein (57)

have presented evidence that CELD^^ and pyrogen

FI^q

are

measures of the same biological substance, therefore in in
terpretation of rabbit pytogen tests similar to
applicable.
FI^q

CELD^Q

is

There is no significant difference between the

of the LPS and crude ribosomes, (Table 3) that for LPS

being 17 ug and that for crude ribosomes being 21 pg (Fig. 3).
Again, 5-fold dilutions were utilized in execution of the
test, so that either preparation may contain four times as
much endotoxin as the other.

As with the

CELD^q

tests, endo

toxin pyrogenicity of the crude ribosome preparation may have
been amplified by ribosome presence in the mixture.
The quality or form of febrile response in the pyrogen
tests contributes additional information about the prepara
tions,

Classically, endotoxin will induce a biphasic re

sponse in rabbits (46).

That is, there will be an early

febrile response followed by a drop, then another rise in
temperature.

This type of response occurs only with endo

toxin injection, and can be used to determine whether the
febrile response is induced by endotoxin or other substances.
The febrile responses induced by our GC LPS and GC crude
ribosomes were biphasic.

Therefore, endotoxin in the
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Table 3. Average rabbit fever response indices to i.v.
injection of GC LSP or GC crude ribosomes.
GC
LPS
Dose

Average Fever
Index (cm2)

0.4

6.4

2.0

Dose
(pg)

Average Fever
Index (cm2)

0.625

15.2

21.8

2.5

18.0

M
o
o

(ug)

GC
Crude ribosomes

28.1

10.0

33.2

50.0

50.8

40.0

45.6

F:40*

F:40.

17 pg

21 pg

* = as determined by the method of Keene et al. (46).

Fig. 3. Average rabbit fever response indices to i.v. injection of GC LPS or GC crude
ribosomes - determination of FI^^.
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preparations was the moiety responsible for inducing the
fever (Fig. 4).
All three endotoxin tests gave the same results.

This

demonstrates similar levels of endotoxic activity for both
preparations.

It was therefore necessary to compare MIF

tests responses to equal concentrations of each preparation.
The reason for a comparison of responses to both preparations
is to determine whether it is endotoxin or ribosomes within
the crude ribosomes that is the agent responsible for re
sults obtained.

If the crude ribosome preparation (in con

centration equal to the LPS preparation) causes a greater
reaction (more migration inhibition) in the MIF system than
does the LPS preparation, then a moiety other than endotoxin
in the crude ribosome preparation is the responsible antigen.
In Vitro CMI Studies:

The area of migration of cells without

antigen was designated as 1.00.

Areas of migration with GC

crude ribosomes or GC LPS as antigen were expressed as an
index in relation to the area of migration without antigen.
An index of migration of 0.60 indicates cell migration 60%
of that without antigen; or, in other words, 40% inhibition
of migration.

The area of migration designated as 1.00 was

determined for each subject due to difference in cell migra
tion between tests by using macrophages from different indi
vidual guinea pigs.
20% between tests.

Such differences were usually less than

Fig. 4.

Representative biphasic rabbit febrile response to i.v. injecfcion of endotoxin.
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It was necessary to compare responses of lymphocytes
from patients and control persons to GC LPS and GC crude ribosomes in establishing criteria by which samples would be
diagnosed as positive or negative.

That is, the index of

migration using GC crude ribosomes as antigen was compared
to the index using GC LPS as antigen.
Concentrations of antigen ranging from 1 to 200 yg were
used at various times in search of a reliable concentration.
Responses to 10 pg crude ribosomes were inconsistent (Table
4).

Of nine patients sampled, four did not respond with in

hibition of more than 20%.

Therefore, 10 wg crude ribosomes

was rejected as a reliable concentration for diagnosis.

One

hundred yg of antigen elicited consistent responses by cells
from patients and from control subjects (Table 4).
Tradition dictates 20% inhibition, or 0.80 index of
migration as the threshold response for a positive diagnosis
(37).

Samples with areas of migration less than 0.80 would

therefore be diagnosed as positive.

Such a straightforward

diagnosis scheme would be applicable to this model if the
inhibition of cell migration were entirely due to cellmediated immunity.

But, as mentioned earlier, the crude

ribosome preparation may be contaminated with homologous LPS
during isolation, and monocytes may respond in peculiar ways
to the presence of endotoxin (52).

Therefore the endotoxin

contamination may mimic a CMI response in the MIP test.

This

can be witnessed by observing indices of migration for both
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Table 4. MIF test responses of culture positive persons
tested on the first day of drug therapy.

Migration Index ****

Patient

GC Crude
Ribosomes
10 yg 100 pg

GC LPS
10 yg 100 yg

**
Index
Ratio

***
Interpretation

6

0.40*

0.34

ND

ND

—

Pos

7

0.52*

0.59

ND

ND

-

Pos

9

0.87*

0.79

ND

ND

—

Pos

10

0.78

0.75

1.20

0.94

0.80

Pos

12

1.31

0.63

0.75

0.64

0.99

7

13

0.90

0.60

0.82

1.00

0.60

Pos

14

0.53

0.57

0.95

0.84

0.68

Pos

15

0.71

0.86

0.76

0.69

1.24

Nea

16

0.80

0.65

0.77

0.88

0.76

Pos

ND = not done.
* = 20

g instead of 10

g were used.

** = ratio of indices with 100 yg crude ribosomes to 100 yg
LPS.
*** = migration <0.80 with 100 yg crude ribosomes and ratio
of indices <1.00 as criteria for positive.
**** = migration index defined as the area of migration with
antigen expressed as a decimal fraction of the area of migra
tion without antigen.
? - no interpretation made, because values were not defi
nitely positive or negative.
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patients and controls when their cells were incubated with
100 yg GC crude ribosomes.

If we use only the 0.80 criteria,

8 of 9 patients responded with positive diagnosis, but 4 out
of 9 controls also responded with migration inhibited by
more than 20% (Table 5) -- i.e., there were 44% false posi
tive diagnosis.
It was therefore necessary to establish an extra cri
terion which would take into account the presence of LPS con
tamination.

As demonstrated in the above bioassays, 100 pg

crude ribosomes and 100 pg LPS exhibited approximately equal
endotoxicity.

Cells which are inhibited from migrating more

by the crude ribosomes than the LPS can be said to be sensi
tive to a factor other than, or in addition to, LPS in the
crude ribosomes preparation — i.e., ribosomes.

We therefore

established the second criterion, that the migration index
of cells incubated with crude ribosomes be less than the
index of the cells with LPS.
Five of the 6 GC patient cells tested with both 100 pg
LPS and 100 pg crude ribosomes responded more to the crude
ribosome preparation than to the LPS.

Even more significant

was the demonstration that, of the four false positive by
the 0.80 criterion alone, three were interpreted as negative
by this additional criterion.

In other words, only 1 of the

9 controls (11%) remained a false positive when both cri
teria were employed — the only false positive being patient
7.

38

Table 5. MIF test responses of gonococcal negative control
sub]ects.

Migration Index

Control
1

GC Crude
Ribosomes
10 yg 100 ug
0.71*

***
**

GC LPS
10 ng 100 pg

* **

Index
Ratio

Interpre
tation

1.40

ND

ND

-

Neg

—

Neg

2

ND

1.00

ND

ND

3

0.79

1.23

0.60

0.61

2.00

Neg

4

0.80

0.69

0.62

0.41

1.68

Neg

5

1.05

0.91

1.08

0.79

1.15

Neg

6

0.74

0.65

0.82

0.58

1.12

Neg

7

1.50

0.79

0.93

1.16

0.68

Pos

8

1.91

1.51

1.93

1.71

0.88

Neg

9

0.90

0.74

0.74

0.56

1.20

Neg

ND = not done.
* - 20 pg instead of 10 ijg were used.
** = ratio of indices with 100 yg crude ribosomes to 100 pg
LPS.
*** = migration <0.80 with 100 yg crude ribosomes and ratio
of indices <1,00 as criteria for positive.
**** - migration index defined as the area of migration with
antigen expressed as a decimal fraction of the area of migra
tion without antigen.
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Diagnosis of all subjects was therefore made on the
basis of two criteria for positive interpretation:

1) migra

tion with 100 yg ribosomes must be less than 0.80, and 2) the
ratio of the indices for 100 pg crude ribosomes to 100 yg LPS
be less than 1.00.

When these two criteria were used, there

was 78% correct diagnosis of GC culture positive individuals,
and an 11% rate of false positivity.

Diagnosis of GC culture

positive persons was actually 89% correct, when we adhere
strictly to the criteria.

But, because data from patient

12 was on the threshold of positivity, we interpreted him as
neither positive nor negative.
Comparison and statistical analysis of differences be
tween patient and control indices of migration to 100 yg GC
crude ribosomes (Tables 4 and 5) indicates a level of signi
ficance of p <0.03.

A similar analysis of the differences

between the index ratios of patients and controls (Tables 4
and 5) indicates a level of significance of p <0.13.
Persons with stimulated cell-mediated immune systems
were examined to determine what cross reactivity may occur
(Table 6).

Because mycobacterial infection and vaccination

stimulates CMI, persons vaccinated with M. bovis strain BCG
were examined.

Despite a small sampling, various observa

tions can be made

First of all, lymphocytes from these

persons responded vigorously to both the LPS and crude ribosomal preparations.
well below 0.80.

This is evidenced by migration indices

Secondly, because the ratio of the indices
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Table 6.

MIF test responses of subjects immunized with BCG.

Migration Index

Person

GC Crude
Ribosomes
10 yg 109 yg

** * *

**

GC LPS
10 yg 100 yg

Index
Ratio

** *

Interpre
tation

1

0.65

0.29

ND

ND

Pos

2

0.54

0.62

0.59

0.30

2.05

Neg

3

0.56

0.28

0.41

0.26

1.03

Neg

ND - not done.
* = 20 pg instead of 10 yg were used.
** = ratio of indices with 100 ug crude ribosomes to 100 pg
LPS.
*** = migration <0.80 with 100 yg crude ribosomes and ratio
of indices <1.00 as criteria for positive.
**** = migration index defined as the area of migration with
antigan expressed as a decimal fraction of the area of migra
tion without antigen.
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was above 1.00, 2 of the 3 persons samples were diagnosed as
negative.

The other was not tested against LPS, so that a

ratio of indices was not established.
Characterization of CMI to GC infection entails examin
ation of both inception and termination of the response.
Therefore, this investigation monitored patient responses to
the MIF test at various intervals post-therapy (Table 7).
Again, because of differences in degree of sensitization, we
expected and found varied lengths of sensitization.

The only

patients tested at one week post-therapy, patients 2 and 3,
were still sensitive by our established criteria, and simi
larly, at six weeks, patient 5 had retained sensitivity to
the antigen.
Eight weeks appears to be somewhat of a threshold for
retention of sensitivity; patient 1 had converted to nega
tive.

Other negative diagnoses were found for patient 1

tested 10 weeks post-therapy and patients 4, 8, and 10 tested
at 16 weeks post-therapy.

Patient 5 remained strongly posi

tive even 20 weeks post-therapy.

It appears that 8 to 16

weeks post-therapy may be the threshold for reversion to neg
ative.
Based upon statements concerning duration of infection
prior to treatment and MIF testing (Table 8), it was ob
served that even patients who contacted the disease 7-10 days
before testing, responded positively (patients 2, 3, and 6).
It may therefore be inferred that within 10 days after

Table 7. MIF test responses of culture positive persons tested on the first day
of drug therapy, and at various intervals post-therapy.

Patient
1

2
3

5

8
10

0
8
20
0
1
0
1
0
16
0
6
20
0
16
0
16

Migration Index ****
**

GC Crude Ribosomes
10 yg
100 yg
0.53*

wk
wk
wk
wk

0.69
0.78
0.96*
0.58*
0.13*

ND

0.75

0.82

0.59

0.52
0.89

0.41
0.34

0.08

0.93*

0.60
1.30
0.50
0.56
0.58

wk
wk

1.05
0.72
0.58*
0.57
0.78

0.71*

wk

ND

0.33

1.12

wlc

0.20
0.65

0.75*

wk

0.92

GC LPS
.10 yg
100 yg

0.72

1.29
0.75
0.81

1.20

ND
ND
ND
ND
ND
1.18
ND
0.96
0.61
ND
1.20
0.94

0.78

0.76

MD

ND
ND
ND
ND
1.37
ND
0.80

0.50
ND
0.94

Index
Ratio
-

1.25
0.92
-

-

-

-,

o
1—1
H• ,

4

Time
after
therapy
when
tested

-

0.58
0.95
-

1.07
0.80
1.06

** *

Interpre
tation
Pos
Neg
Neg
Pos
Pos
Pos
Pos
Pos
Neg
Pos
Pos
Pos
Pos
Neg
Pos
Neg

wk = weeks.
ND = not done.
* = 20 ug instead of 10 yg were used.
** = ratio of indices with 100 pg crude ribosomes to 100 yg LPS.
*** = migration <0.80 with 100 yg crude ribosomes and ratio of indices <1.00 as
criteria for positive.
**** = Migration index defined as the area of migration with antigen expressed as
a decimal fraction of the area of migration without antigen.
K)

Table 8.

Medical histories of all patients tested.

Patient

Sex

Age

1
2
3
4
5
6
7
8
9
10
12
13
14
15
16

F
F
M
F
F
M
M
F
F
F
F
M
M
M
M

19
19
20
21
24
23
20
19
20
20
19
27
17
20

24

Estimated
Duration
Prior to Testing
2
10
10
6
1
5
1
12

months
days
days
weeks
NA
week
NA
months
month
NA
months
NA
NA

2 weeks
NA

Clinical
Symp
Asymp
Symp
Asymp
Symp
NA

Symp
Asymp
NA
Symp
Asymp
Symp
Symp
Asymp
Symp

Venereal Disease
History
None
None
June 75(Trichuria)
None
NA

NA
July 75(GC)
None
None
None
None
NA
None
None
NA

Symp = symptomatic
Asymp = asymptomatic
NA = not available

A.
CrJ

44

gonococcal contact, sensitization takes place.

Patient 15

failed to respond with positive diagnosis with MIF testing
two weeks post-contact.

Therefore, the period of time before

sensitization takes place, as well as the period of time be
fore sensitization ceases, is a variable of individual dif
ferences of infection.
Cumulative MIF Test Response Results ;

The control group had

an average migration index of 0.99 when incubated with 100 yg
crude ribosomes (Fig. 5).

The GC culture-positive group, on

the other hand, responded to 100 yg crude ribosomes with an
average migration index of 0.55 — i.e., 45% inhibition of
migration.

Although there was a distinct difference between

the two groups of subjects, when cells were incubated with
100 yg crude ribosomes, they responded equally to 100 yg LPS
-- i.e., an average index of 0.83 for each group.

The BCG

immunized group responded significantly to both crude ribo
somes and LPS.

However, unlike the GC culture-positives,

the BCG group responded more to 100 yg LPS than to 100 yg
crude ribosomes.

45
Fig. 5. Cumulative averages of MIF test responses to 100 ug GC
crude ribosomes or 100 ug GC LPS. Migration index is the area
of migration with antigen expressed as a decimal fraction of
migration without antigen. Bars represent the ranges of responses.
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CHAPTER IV
DISCUSSION
In the present study, CMI of gonorrhea patients to
a gonococcal crude ribosome preparation was demonstrated in
vitro.

Statistical analysis of the data indicated a signi

ficant (p <0.02) difference in the level of responses be
tween lymphocytes from patients and control subjects.

Pre

vious to the present investigation, studies of lymphocyte
transformation ^ vitro had been used to demonstrate CMI
against N. gonorrhoeae protoplasm preparations (27, 31, 49).
Grimble and Mclllmurray (31) observed positive responses with
lymphocytes from 10 of 12 patients studied, but they also
noted that lymphocytes from 4 of 10 control subjects gave
false positive responses.
In the present study, 20% inhibition of migration was
used as the threshold for a positive response, and 8 of 9
patients gave positive responses.

However, 4 of 9 uninfec

ted controls also had such responses.

It was considered

that the positive responders were sensitized to some moiety
within the crude ribosome preparation.

Alternatively, some

thing within the preparation may have caused lymphocytes to
mimic CMI when incubated with it.
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Because crude ribosomes
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might have been contaminated with LPS during their isolation,
it was decided to test an LPS preparation (with endotoxicity
equal to that of the crude ribosomes) in parallel with the
crude ribosome preparation.

When incubated with GC LPS,

lymphocytes from infected patients and from uninfected con
trol subjects nonspecifically inhibited migration of guinea
pig macrophages.

Others have reported that LPS might inhibit

migration in MIF tests (34).

This raised the question of

whether or not LPS within the crude ribosome preparation was
responsible for the migration inhibition observed.

It was

noted that lymphocytes from infected patients responded with
more migration inhibition to the crude ribosome preparation
than they did to the LPS preparation, whereas lymphocytes
from uninfected controls did not respond more to the crude
ribosome preparation than to the LPS preparation (p <0.13).
Because the antigenic preparations of Grimble and Mclllmurray
(31), and of others (27, 49) were ill-defined, moieties act
ing as nonspecific mitogens may have been present within
their preparations, and were responsible for eliciting the
high rate of false positives.
There appears to be some question as to the nature of
the antigen, within the crude ribosome preparation, which was
indicating the patient's sensitivity; i.e., what moiety was
the agent to which lymphocytes from GC patients had become
sensitized?

Several possibilities were considered:
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1)

In the present study, incubation of lymphocytes with

the LPS preparation and with the crude ribosomes preparation
did not give similar responses, therefore LPS could not have
been the antigen.

Although LPS was not the specific antigen,

it might have played a role as a molecular carrier of the
antigenic determinant.
2)

Was nascent protein, which was being synthesized on

the ribosomes, the specific antigen within the crude ribosome preparation?

Most of the nascent protein was probably

removed during ribosome isolation.

Photographs of Schlieren

patterns of the crude ribosome preparation illustrated that
the ribosomes had dissociated into 30S and 50S subunits, and
therefore would have released any nascent protein (36).

When

the ribosomes were centrifuged, the nascent protein would
have remained in the supernatant fluid and would have been
discarded.

Any homogeneous nascent protein which did remain

would have been in such low concentration that it is very
unlikely to have been the specific antigen in the crude ribo
some preparation.
3)

Buchanan et a^. (13) have demonstrated that pilin or

pili could be used as a specific antigan for seo-testing.

Is

it possible that this gonococcal protein was contained within
the crude ribosome preparation and was responsible for CMI
results obtained?

Individual pilin molecules, as well as

pili, were probably eliminated in the same manner as was
nascent protein, since their sedimentation coefficient would
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be very low.

This is verified by lack of perturbation in

the baseline of the Schlieren photographs of the GC crude
ribosomes.

Therefore, pilin and pili may be eliminated from

consideration as the antigen responsible for specific migra
tion inhibition observed.
4)

Esquenazi and Streitfeld (27), Grimle and Mclll-

murray (31), and Kraus et

(49) prepared an antigen of

sedimented protoplasm extracts of the gonococcus.

Entities

with sedimentation properties similar to those of the crude
ribosomes must have been contained in their antigenic prepa
rations.

The ribosomal material which I employed was a

better prepared and defined preparation than a simple proto
plasmic extract.

Methods used for preparation of the

ribosomes eliminated many soluble cytoplasmic factors con
tained in the other preparations.
5)

Since patients with gonorrhea do mount an immuno

logical response to several GC antigens (3, 11, 38, 500, 51,
71, 83), it was necessary to utilize an antigen in CMI or
sero-testing which will best demonstrate specific sensitivity.
Ribosomes make up 25% of the total cellular mass of some
kinds of bacterial cells (85), and therefore ribosome struc
tural proteins are immunogens which would be generally
plentiful, and which might elicit sensitization during
infection.

Therefore, ribosome structural proteins provide

a high level of homogeneous protein to which immunocompetent
cells may become sensitized.

Although ribosome structural
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proteins have not been proven to contain the antigenic
determinant responsible for the MIF test results, they are
implicated as the antigen.
In this investigation, a preparation which contained GC
ribosomes was used as an antigen.

Although only a pilot

study, the study did demonstrate that gonorrhea patients can
become specifically sensitized to a moiety within a gonococ
cal crude ribosome preparation.
Attempts to develop an immuno-diagnostic test for de
tection of gonorrhea have been confronted with difficulties
in detecting sensitization, either humoral or cell-mediated.
This project encountered similar problems.

In order to

detect consistently CMI against the crude ribosome prepara
tion, it was necessary to use ribosomal concentrations of
100 yg/ml.

There are various possible explanations for the

need of a high antigen concentration in detecting sensitiza
tion.

One problem may have been the possible degradation of

the antigen used in the test.

The GC were killed by pouring

fresh cells over ice and holding them at 4°C overnight.
Although the cold would retard enzymatic autolysis, it would
not stop it completely.

Many of the antigens might have

been degraded, therefore, although 100 yg/ml of the final
preparation was used, only a fraction of it could have been
of specific, intact antigen.
Another possible explanation for difficulty in detecting
sensitization might have been that there was a very low level
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of sensitization in the infected patients.

There are several

possible mechanisms for the failure of the patients to de
velop sensitization.

First, the immunogens could have been

autolyzed during infection before immunocompetent cells were
able to process them.

Second, since gonorrhea is a superfi

cial infection, relatively isolated from the immune system,
immunocompetent cells might have only infrequently reached
the immunogens for sensitization.
The time factor involved in sensitization is worthy of
note.

Esquenazi and Streitfeld (27) have reported that lym

phocytes from gonococcal patients responded to various
gonococcal sonicates with blastogenesis ^ vitro.

They dem

onstrated sensitization 5 days after gonococcal contact and
cessation of sensitivity 5 weeks after therapy was begun.
Within the limitations set by sampling, results herein paral
leled theirs; i.e., sensitization to the gonococcal crude
ribosome preparation was demonstrated to begin approximately
7 days after contact, and sensitivity was observed to cease
8 to 16 weeks post-therapy.

Data obtained from a single

patient (#5) indicated that delayed hypersensitivity was
present as long as 20 weeks post-therapy.

Since GC cannot be

cultured from urogenital areas of patients 2 days after suc
cessful antibiotic treatment (54), viable GC were probably
cleared from the system.

If patient 5 had been cured, the

immunogens should have been cleared and the patient would
have returned to negative diagnosis.

Because of the high
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level of sensitivity remaining at 20 weeks in patient 5,
this suggests active infection.

Though generally effective,

treatment does not result in cures in all cases.

Most re

searchers define as successful a 95% cure rate (depending on
the program and type of drug therapy used) (55, 77).

Since

subjects were tested on a voluntary basis, the laboratory
was unable to examine patient 5 to see whether she had been
cured of the infection.
The amount of stimulus necessary to elicit demonstrable
sensitization requires mention.

Kraus et a]^. (50) have re

ported that a sequence of two infections was required before
CMI could be detected.

The present studies were able to

detect a CMI response in most of the patients after a single
infection.
ference.

Two possible reasons are evident for this dif

Either, 1)

MIF testing is a more sensitive test

than is blastogenesis for detecting CMI to N. gonorrhoeae
infection, or 2)

The antigenic preparation contained an

antigenic determinant which detects sensitization better than
did the preparation used by Kraus.
The MIF test employed to demonstrate CMI is a very te
dious procedure.

MIF testing, therefore, is not suggested

as a diagnostic methodology to screen populations for GC in
fection.

However, results of this ^ vitro study demonstrate

the potential fruitfulness of studying various moieties from
the GC crude ribosome preparation as ^ vivo skin test anti
gens.

Such a test, if developed, would provide an ideal

diagnostic aid in detecting and treating the reservoir of
infections, thereby reducing and maintianing gonococcal in
fection at reasonable levels.

CHAPTER V
SUMMARY
The purpose of this investigation was to determine
whether cell-mediated immunity (CMI) could be demonstrated
to gonococcal crude ribosomes.

As the investigation evolved,

it was necessary to consider factors within the crude ribo
somes, which had been isolated by differential ultracentrifugation, that may lead to nonspecific responses to endotoxin
present.
In MIF tests lymphocytes from patients with gonorrhea
were found to respond significantly more than did lympho
cytes from negative control subjects when incubated with GC
crude ribosomes.

This indicated that persons infected with

GC were sensitized to a moiety within the crude ribosome
preparation.

Bioassays failed to distinguish crude ribosomes

from LPS in terms of endotoxicity.

To correct the results

for effects of LPS within the crude ribosomes, lymphocytes
were also incubated in MIF tests with concentrations of LPS
equal to that present in the crude ribosomes.

It was ob

served that GC LPS nonspecifically induces lymphocytes from
patients, controls, and BCG vaccinated persons to inhibit
guinea pig macrophage migration.

Crude ribosomes, on the

other hand, specifically inhibit guinea pig macrophages
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incubated with lymphocytes of patients with gonorrhea.

Based

upon lymphocyte responses to the two gonococcal preparations,
correct diagnosis of 7 of 9 infected patients and 8 of 9
negative controls was made.
Using criteria established from lymphocyte responses to
the two preparations, several patients were tested at various
intervals post-therapy.

Based upon these follow-up studies

and medical histories it was determined that sensitization
was established within 2 weeks of the contraction of infec
tion, and it subsided 8 to 16 weeks post-therapy.
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